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Objective  To assess the practical diagnostic value of facial nerve antidromic evoked potential (FNAEP), we 
compared it with the diagnostic value of the electroneurography (ENoG) test in Bell’s palsy. 
Methods  In total, 20 patients with unilateral Bell’s palsy were recruited. Between the 1st and 17th days after 
the onset of facial palsy, FNAEP and ENoG tests were conducted. The degeneration ratio and FNAEP latency 
difference between the affected and unaffected sides were calculated in all subjects.
Results  In all patients, FNAEP showed prolonged latencies on the affected side versus the unaffected side. The 
difference was statistically significant. In contrast, there was no significant difference between sides in the normal 
control group. In 8 of 20 patients, ENoG revealed a degeneration ratio less than 50%, but FNAEP show a difference 
of more than 0.295±0.599 ms, the average value of normal control group. This shows FNAEP could be a more 
sensitive test for Bell’s palsy diagnosis than ENoG. In particular, in 10 patients tested within 7 days after onset, an 
abnormal ENoG finding was noted in only four of them, but FNAEP showed a significant latency difference in all 
patients at this early stage. Thus, FANEP was more sensitive in detecting facial nerve injury than the ENoG test 
(p=0.031).
Conclusion  FNAEP has some clinical value in the diagnosis of facial nerve degeneration. It is important that 
FNAEP be considered in patients with facial palsy at an early stage and integrated with other relevant tests.
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INTRODUCTION
Bell’s palsy is caused by damage to the 7th cranial 
nerve, but in most cases it is idiopathic. It is known to oc-
cur due to compression and ischemia resulting from in-
flammation and edema of the facial nerve, caused by viral 
infection [1]. Bell’s palsy may involve acute unilateral fa-
cial palsy, sensory impairment, and drooling. These clin-
ical signs and a physical examination are fundamental 
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to the diagnosis of Bell’s palsy. A diagnosis of Bell’s palsy 
is typically based on symptoms and by ruling out other 
disorders, such as central nervous system injury, facial 
tumors, certain cancers, and autoimmune diseases. De-
veloping over several hours or up to 2–3 days, the typical 
symptoms include asymmetric smile, slurring of words, 
muscle weakness, and an inability to close an eye. A defi-
nite diagnosis needs electrodiagnostic tests to examine 
nerve damage and its severity, along with a prognostic 
prediction. In this regard, electrodiagnostic tests, such as 
needle electromyography (EMG) and electroneurography 
(ENoG), have been used in the diagnosis since the 1970s. 
EMG detects nerve damage, identifying whether sponta-
neous abnormal activities occur during the resting state 
in facial muscles, such as the frontalis, obicularis oculi, 
and orbicularis oris muscles, and whether motor unit ac-
tion potential changes occur [2-10]. In the case of ENoG, 
nerve damage is confirmed when waveform amplitude 
is smaller than half of that on the unaffected side [10-12]. 
However, both tests may be less accurate when they are 
performed within a week after the onset of Bell’s palsy. 
This is because they can only examine the extratemporal 
segment of the facial nerves [2-10].
Early treatment is crucial in recovery from Bell’s palsy, 
which needs early detection of nerve damage. A facial 
nerve antidromic evoked potential (FNAEP) study is the 
only electrodiagnostic tool for evaluating the intratempo-
ral segment of the facial nerves, so it is effective to diag-
nose the early stage of Bell’s palsy, within a week of onset 
[13]. However, previous studies examining FNAEP have 
been conducted in animal experiments [14,15], most of 
which were focused on FNAEP waveforms [13], and there 
are very few reported studies on the diagnostic value of 
FNAEP latency. In this study, we sought to determine 
a reference value for FNAEP latency and to compare 
FNAEP and ENoG in terms of diagnostic value in Bell’s 
palsy, especially in the early stages, within 1 week.
MATERIALS AND METHODS
This study was conducted on 20 patients with Bell’s pal-
sy from March to December 2012, who underwent FNAEP 
and ENoG tests on the same day. Written informed con-
sent was obtained from all subjects prior to the study. 
Before the examination, to check the severity of the 
facial nerve injury, we used the House-Brackmann scale 
between I (normal) and VI (no movement) [16]. FNAEP 
was used to measure the latency difference between af-
fected side and unaffected side, and ENoG was to calcu-
late the degeneration ratio of the facial nerve compared 
with the unaffected side. ENoG was performed using the 
Medelec Synergy EMG equipment (Oxford Instrument 
Medical Ltd., Surrey, UK) with a built-in monitor, bipolar 
stimulator, and discoid electrodes. Facial nerve trunks 
were stimulated by supramaximal stimuli through the bi-
polar stimulator at the stylomastoid foramens, and com-
pound muscle action potentials (CMAPs) were measured 
through recording electrodes placed on the ala nasi. The 
reference electrode was placed on the nasolabial folds 
(with a 2-cm interelectrode distance). The ground elec-
trode was placed on the forehead. CMAP amplitude was 
the peak to peak amplitude. Calculation of the degenera-
tion ratio was as follows: 100 × (1 – amplitude on affected 
side / amplitude on unaffected side) [4]. The blink reflex 
test was conducted with the same EMG equipment un-
der the following conditions: a pulse duration of 100 μs, 
a repetition rate of 1 Hz, a bandwidth of 3 Hz to 10 kHz, 
a sensitivity of 500 μV/division, and a sweep speed of 10 
ms/division. Active electrodes were placed on the lower 
lid (orbicularis oculi muscles) with the patient in a supine 
position, a reference electrode was placed on the side of 
the nasal bones, and a ground electrode was placed in 
the middle of the chin. Stimuli were given to the supraor-
Fig. 1. Locations of active electrode (black arrow), refer-
ence electrode (white arrow), and stimulator. 
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bital notches using a stimulator at 20–40 mA. 
For the FNAEP, we used same equipment as described 
above. The reference, active, and ground electrodes were 
placed on the earlobes, the posterior walls of the external 
auditory meatuses, and the dorsum of the hand respec-
tively. Stimuli were given 50 times in total at a stimulus 
intensity of 20 mV and a stimulus rate of 1 time/s at the 
stylomastoid foramen process [17,18] (Fig. 1). Sensitivity 
was adjusted to 2 μV/division and data were recorded by 
an averaging technique. The signal was initially filtered 
at 30 Hz to 3 kHz instead of 2 Hz to 10 kHz as proposed in 
the preliminary study of Zhang et al. [17] to reduce noise 
and fluctuation of the base line. The results were record-
ed for both sides (Fig. 2).
In the control group, consisting of 19 normal adults, bi-
lateral FNAEP latencies were measured in the same way, 
and the mean value of latency difference between bilat-
eral sides was set as the reference value. The Wilcoxon 
signed-rank test was used to verify the significances of 
mean FNAEP latency differences between both sides 
in patients and the control group. Additionally, a check 
was kept on whether abnormal findings were observed 
in the patient group in the FNAEP and ENoG study. The 
McNemar test was used to ascertain whether the two 
methods differed significantly in diagnostic sensitivity. 
With the ANOVA test, an analysis was made of the cor-
relation between ENoG and the House-Brackmann scale 
and between FNAEP latency differences and the House-
Brackmann scale.
All data were analyzed using the SPSS ver. 18.0 (SPSS 
Inc., Chicago, IL, USA). The significance level was set at 
p<0.05.
RESULTS
Patient characteristics and reference values
Demographic and clinical characteristics of subjects 
are presented in Table 1. In the control group, the mean 
difference in FNAEP latency was 0.295 ms (2 standard 
Table 1. Demographic and clinical characteristics of sub-
jects
Patient 
group
Control 
group
Gender (male:female) 10:10 15:4
Lesion side (right:left) 12:8 -
Age (yr) 35±18 31±5
Disease duration (day) 7.3±8.1 -
House-Brackmann grading 
system
Grade V 3 -
Grade IV 6 -
Grade III 4 -
Grade II 7 -
Values are presented as number or mean±standard de-
viation.
Fig. 2. Waveform of facial nerve 
antidromic evoked potential. (A) 
shows intact side and (B) shows 
affected side.
Table 2. Comparison of FNAEP latency between Bell’s 
palsy patients and the controls
Patient group Control group
Latency difference (ms) 3.715 (7.163) 0.295 (0.599)
p-value <0.01* 0.3
Values are presented as number or mean (two standard 
deviation).
FNAEP, facial nerve antidromic evoked potential.
*p<0.05.
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deviation [SD]=0.599), which was used as the reference 
value in this study (Table 2). The mean of FNAEP latency 
was 10.392 ms (2 SD=2.098). The mean age of the men 
(n=15) was 31.1 years (2 SD=6.2) and their latency aver-
aged 10.603 ms (2 SD=1.086). The mean age of the wom-
en (n=4) was 29.5 years (2 SD=2.0) and their latency was 
9.600 ms (2 SD=4.082) on average. In all patients, FNAEP 
latency tended to be delayed on the affected side. Ad-
ditionally, there were statistically significant differences 
between the affected and unaffected sides. In the control 
group, however, there was no significant difference in 
FNAEP latency between the sides (Table 2).
FNAEP and ENoG sensitivity for Bell’s palsy diagnosis
In 8 of 20 patients who manifested clinical symptoms of 
Bell’s palsy, the degeneration ratio was within the normal 
range (<50%). Thus, it could not be ascertained whether 
they had definite facial nerve damage [10-12]. However, 
in those patients, the mean difference of FNAEP latency 
was 0.894 ms (reference value+2 SD) and above; thus it 
was judged to be abnormal, so it was possible to diag-
nose facial nerve damage. Diagnostic sensitivities were 
90% and 60% for FNAEP and ENoG, respectively. Of the 
eight patients who were not demonstrated to have neuro-
degeneration by ENoG, six were examined within 7 days 
after the onset of symptoms, five were of House-Brack-
mann grade II, and three were of House-Brackmann 
grade IV, indicating that the FNAEP study may be more 
effective than ENoG at detecting facial nerve degenera-
tion not only in the early stages but also in cases of mild 
symptoms. In contrast, in two patients whose FNAEP 
latencies were within the reference value, their facial 
nerve degeneration was confirmed because their degen-
eration ratios were above 50% (Table 3). However, with 
the McNemar test, there were no significant difference in 
diagnostic sensitivity between the tests (p=0.11).
FNAEP and ENoG sensitivity for Bell’s palsy diagnosis at 
early stage
In 10 patients who were examined within 7 days after 
the onset of symptoms, six patients show degeneration 
ratios within the normal range (<50%). However, in all 
six patients, there were abnormal findings in relation to 
the FNAEP latency difference between the sides (Table 
4). Diagnostic sensitivities were 100% and 40% for FNAEP 
and ENoG, respectively, on the McNemar test (p=0.03). 
These results showed that FNAEP was more statistically 
significantly effective than ENoG in detecting facial nerve 
damage within 7 days. In cases where abnormalities were 
found with both ENoG and FNAEP, the sensitivity was 
50.0% in the patients. For the patients tested within 7 
days, the sensitivity was 40.0%.
Blink reflex sensitivity for Bell’s palsy diagnosis
The blink reflex test was conducted in 19 of 20 patients: 
18 showed abnormalities, and thus the sensitivity was 
94.7%. Of the nine patients who had been suffering from 
the disease for less than 7 days, eight showed abnormali-
ties on the blink reflex test; thus the sensitivity was 88.9%. 
The sensitivity was higher with the blink reflex test than 
with ENoG. In cases where ENoG and blink reflex test 
was performed altogether, the sensitivity was 52.6% in all 
patients. For the patients tested within 7 days, the sensi-
tivity was 88.8%.
FNAEP and ENoG for prognosis of Bell’s palsy 
The House-Brackmann scale was applied to all 20 pa-
tients with Bell’s palsy. The degeneration ratios averaged 
32.5%, 59.8%, 62.8%, and 78.6% in patients graded II, III, 
IV, and V, respectively. The degeneration ratio tended to 
increase as the House-Brackmann grade increased; this 
was statistically significant (p=0.006). However, there was 
no significant difference between House-Brackmann 
Table 3. ENoG degeneration ratio and FNAEP latency dif-
ference in Bell’s palsy patients
FNAEP latency difference (ms)
ENoG degeneration 
ratio (%)
≥50 <50
>0.295±0.599 10 8
≤0.295±0.599 2 0
ENoG, electroneurography; FNAEP, facial nerve anti-
dromic evoked potential.
Table 4. ENoG degeneration ratio and FNAEP latency dif-
ference in Bell’s palsy patients within 7 days after onset
FNAEP latency difference (ms)
ENoG degeneration 
ratio (%)
≥50 <50
>0.295±0.599 4 6
≤0.295±0.599 0 0
ENoG, electroneurography; FNAEP, facial nerve anti-
dromic evoked potential.
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grade and FNAEP latency difference, and FNAEP did not 
reflect the degree of facial nerve injury (p=0.181).
In 10 of the 20 patients, we checked whether symptoms 
had improved in a month. In the two patients whose 
FNAEP latencies were within the normal range, their 
symptoms did not improve on the House-Brackmann 
grading system, whereas in the five patients with normal 
ENoG findings, their symptoms improved a month later 
(Table 5). As a result, ENoG tended to be more closely as-
sociated with disease prognosis.
DISCUSSION
Unlike other electrodiagnostic tests, the FNAEP study 
makes it possible to check for facial nerve damage be-
cause it stimulates the outer part of the temporal bone 
and receives a signal from the inner part. FNAEP has 
the advantage of detecting facial nerve damage before it 
spreads to the outer part of the temporal bone.
In a previous study [13], 109 patients who underwent 
FNAEP within 7 days after Bell’s palsy symptoms did not 
show triphasic waveforms, but showed abnormal wave-
forms. Of 88 patients who showed biphasic waveforms, 
82 recovered fully. Nearly half of patients who showed 
monophasic waveforms or no response did not recover 
sufficiently. Thus, they suggested that FNAEP was highly 
effective in diagnosing the early stages of Bell’s palsy and 
predicting the prognosis. However, their study focused 
on the morphology of the FNAEP waveforms, and there-
fore is directly comparable with this study focused on dif-
ferences of latency between the sides.
Another study measured evoked potentials from the 
posterior walls of the external auditory meatuses and 
confirmed specific waveforms and prolonged latencies 
in facial palsy [14]. However, it is also not reasonable 
to compare their study conducted on animals with this 
study. Another study reported that three healthy people 
showed triphasic waves on FNAEP study, but that five of 
seven Bell’s palsy patients revealed no response on the 
FNAEP study [15]. That study was conducted in a smaller 
number of patients than the present study, and moreover, 
did not deal with latency.
A recent study conducted on 46 patients with unilat-
eral Bell’s palsy reported that FNAEP enabled the detec-
tion of early facial nerve damage in the intratemporal 
bone, and that the prognosis could be predicted through 
the range of decrease in waveform amplitude and the 
increase in onset latencies [17]. Those results were con-
sistent with this study: the increase in FNAEP latency is 
useful to detect facial nerve damage at an early stage. 
Our study is significant in that a comparison was made 
between FNAEP and ENoG regarding diagnostic value. In 
this study, the latency difference exceeded the reference 
value in 18 of 20 patients diagnosed with Bell’s palsy, 
showing that latency should be used as a diagnostic scale 
in addition to FNAEP waveforms.
In this study conducted on 20 patients with Bell’s palsy, 
not all cases could be detected by ENoG, but the eight 
undetected cases did show abnormal findings in the 
FNAEP study. Thus, it appears that FNAEP is useful in 
Table 5. Prognosis of Bell’s palsy patients in one month
Subject no. Gender Age
FNAEP latency difference 
(ms)
ENoG 
degeneration 
ratio (%)
House-Brackmann grading
 system (grade)
Onset 1 mo
1 F 21 >0.295±0.599 ≥50 V II
2 M 36 >0.295±0.599 ≥50 III II
3 M 25 >0.295±0.599 ≥50 IV IV
4 M 47 >0.295±0.599 <50 II I
5 F 41 >0.295±0.599 <50 IV I
6 F 47 >0.295±0.599 <50 II I
7 F 23 >0.295±0.599 <50 IV I
8 M 41 >0.295±0.599 <50 II I
9 M 39 ≤0.295±0.599 ≥50 IV IV
10 F 28 ≤0.295±0.599 ≥50 III III
ENoG, electroneurography; FNAEP, facial nerve antidromic evoked potential.
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diagnosing Bell’s palsy. In the case of 10 patients who 
had been suffering from early stage Bell’s palsy, in par-
ticular, FNAEP showed abnormal findings in all of them, 
whereas ENoG revealed abnormalities in only four of 
them. Regarding the diagnostic sensitivity for facial nerve 
degeneration, FNAEP and ENoG showed 100% and 40%, 
respectively, the difference was statistically significant 
(p=0.031). These results are consistent with a previous 
report that FNAEP was effective in detecting facial nerve 
damage that had not spread to the outer part of the tem-
poral bones, and further supports present theories [17].
Regarding prognostic predictions, the degeneration 
ratio was superior to FNAEP latency. Patients who under-
went ENoGs and whose degeneration ratios were within 
the normal range, showed good prognosis a month later. 
Patients whose FNAEP latency differences were within 
the reference value showed worse prognosis than those 
whose FNAEP latency differences were outside the refer-
ence value. In this study, unlike a previous study [17], 
FNAEP latency was found to be inappropriate for prog-
nostic predictions.
This study has several limitations. Caution is needed 
in generalizing the results, given that this study was 
conducted on small numbers of patients and a control 
group. Second, this study did not thoroughly analyze 
the prognostic predictability of FNAEP latency because 
the follow-up was limited to 1 month after the onset of 
symptoms. Accordingly, a long-term follow-up and a 
large number of patients are needed to confirm FNAEP 
latency’s prognostic value. Third, the FNAEP-recording 
method, used in this study, was proposed from a prelimi-
nary study by Zhang et al. [17]. It can be used with outpa-
tients, without local anesthesia or needle electrode, but it 
differs from the more physiological method proposed by 
Nakatani et al. [13] and Kitani [15]. Thus, further studies 
are needed to compare them. Fourth, the short distance 
between the stimulation site and the recording site leads 
to the possibility of coactivating muscles around the re-
cording site, causing contamination. In this regard, there 
is the need to reduce the activation of muscles around 
recording site, possibly with the use of muscle relaxants.
In conclusion, there were significant differences be-
tween ENoG and FNAEP study in diagnostic sensitivity 
for early stage Bell’s palsy. It is important that FNAEP is 
monitored in patients with facial palsy at the early stage 
and integrated with other relevant test, such as ENoG.
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